Alzheimer's Supplement Scams: Fake Endorsements and How to Shut It Down
A caregiver posted last week that her husband — 64, diagnosed, on medication — was insisting on a memory cure he believed a famous billionaire had endorsed. He hadn't. This is how that machine works.
Key takeaways
- No supplement is approved to prevent, treat or cure Alzheimer's disease. The FDA has issued warning and advisory letters covering more than 58 unproven products.
- Fabricated celebrity endorsements are now the standard technique, including synthetic video and audio of people who have never heard of the product.
- Dementia is the ideal target: anosognosia makes a cure plausible, impaired executive function makes urgency tactics work, and the person holding the card is often the one being sold to.
- The real harm is rarely the price of one bottle. It is the recurring subscription, the escalating upsell, and the delay in getting real assessment and treatment.
- Arguing about the evidence usually fails. Redirecting the decision to their doctor usually works better.
- Reduce access to payment before you try to win the argument — that is the step that actually stops the bleeding.
What this looks like from inside a family
It rarely arrives as an obvious scam. It arrives as hope, with a famous face attached.
Here is the post, lightly trimmed, from a caregiver in one of the groups I follow:
Everything you need to understand the problem is in that paragraph.
A man in his sixties, recently diagnosed, on real treatment, actively searching for something better. A product using a fabricated endorsement from one of the most recognizable people alive. A wife who can see exactly what it is. And a disagreement between two married people about what is true, in which she is right and he is the one holding the credit card.
The specific product she named has been publicly documented as a scam, complete with the invented endorsement. There are many like it, and new ones every month.
Why dementia is the perfect target
Not because people with dementia are gullible. Because the disease removes the specific defenses that fraud relies on you having.
This is worth understanding properly, because it changes how you respond.
- Anosognosia. Many people with dementia genuinely cannot perceive their own deficits — it is a neurological symptom, not denial. A person who does not believe they are impaired is far more receptive to a product that says the impairment can be reversed. The pitch and the symptom fit together.
- Executive function. Comparing claims, weighing sources, holding a decision overnight, resisting a countdown timer — these are exactly the abilities the disease erodes. Urgency tactics work because the capacity to say "let me think about it" is going.
- Hope, which is not a deficit. Someone facing this diagnosis has been told there is no cure. A product saying otherwise is not stupid to want. I would have wanted it.
- Who holds the card. This is the structural problem. The caregiver can usually see the scam clearly and frequently has no legal authority to stop the purchase. In the early and middle stages the person retains full financial control — as they should — and that is precisely the window these products are sold into.
- Isolation. Late-night searching, alone, with nobody to say "show me that."
None of this is a comment on intelligence. Lori repaired hospital laboratory equipment for thirteen years. Competence is not protection.
What the FDA actually says
These are unapproved, misbranded drugs — and the agency has said so repeatedly.
The FDA maintains a standing page on unproven Alzheimer's products, and its position is not ambiguous. Products claiming to prevent, treat or cure Alzheimer's without approval are unapproved new drugs and misbranded drugs. They have not been reviewed and are not proven safe or effective.
Enforcement is real but limited by scale: the agency has issued 12 warning letters and 5 online advisory letters to domestic and foreign companies selling more than 58 unproven products, mostly marketed as dietary supplements through websites and social media.
And the harm the FDA names first is not the money. It is that these products "may be ineffective, unsafe and could prevent a person from seeking an appropriate diagnosis and treatment."
That is the real cost. Time spent on a honey ritual is time not spent getting a proper workup — and in 2026, with treatments that only work at the earliest stages, delay closes doors that do not reopen.
How to recognize one in thirty seconds
You do not need to evaluate the science. The packaging gives it away.
- A famous name. Doctors, scientists, billionaires, television personalities. Increasingly with synthetic video or cloned audio. Real breakthroughs are announced by regulators and medical journals, not by a celebrity in an advert.
- A "simple ritual," "ancient secret," or single household ingredient. Honey, cinnamon, a spice, a fruit. The story is always that something cheap and natural was suppressed.
- "Doctors don't want you to know." A claim of conspiracy is doing the work that evidence would otherwise do.
- Reverses, restores, cures, rebuilds. Words no legitimate product in this space is permitted to use.
- A long video you cannot skip or scrub. Designed so you cannot check the claims at your own pace.
- A countdown, a "last few bottles," a price that expires.
- Multi-bottle bundles at checkout, and a subscription enrolled by default.
- No physical address, no phone number, and reviews that all sound alike.
One more, which is the most reliable of all: if the only places discussing it are pages selling it, it is not a treatment. Search the product name together with the word "scam" first, and see what comes back.
The part that costs the most
Not the bottle. The subscription behind it.
Most of these funnels are not built to sell one product. They are built to establish a recurring charge and then escalate it.
- Auto-renewing subscriptions, disclosed in small type at checkout, with cancellation routed through a phone line that is hard to reach.
- Continuity billing that starts after a "free trial" the buyer does not register as a purchase.
- Escalating upsells — once someone buys, they are on a list of people who buy, which is sold on. A single purchase reliably produces more approaches, not fewer.
- Multiple charges from differently-named entities, which is what makes it hard to spot on a statement.
A caregiver in one of the groups described her father insisting on mailing a paper order form for a commemorative coin, specifically because he could see it would start a subscription and wanted it anyway. That is the difficulty. It is not always that they cannot see it.
What actually works
Reduce access to payment first. Win the argument second, or not at all.
Most families try to argue their way out of this, and most of the time it goes badly. Telling someone with anosognosia that they have been fooled is asking them to accept two things at once — that they were wrong, and that they are impaired. The conversation usually ends in a fight that damages trust you will need later.
Redirect rather than debate:
- "Let's ask Dr. ___ about it." This is the single most useful sentence available. It respects them, it does not require them to concede anything, and it moves the decision to someone with standing. Doctors are generally happy to say no to a product.
- "Let's check for interactions." True, non-confrontational, and it introduces a real reason for delay. Some supplements do interact with real medications.
- "Let's order it together after your appointment." Delay beats denial, and urgency is the mechanism you are defusing.
- Do not mock it. They are not foolish for hoping. If you make hoping shameful, they will stop telling you what they are buying.
Then reduce the access, starting with the least restrictive thing that works:
- Transaction alerts to your phone for every card charge. This is often the whole solution — you find out within a minute instead of a quarter.
- A separate low-limit card for discretionary spending, with the main account not stored anywhere.
- Remove saved card details from the phone, tablet, browser and app stores.
- Become a trusted contact at their bank and brokerage. Most institutions offer this, it does not give you control, and it means somebody calls you when something looks wrong.
- Ask the card issuer about merchant blocks and about disputing recurring charges.
- Get the paperwork in place before you need it — see why a documented diagnosis unlocks so much, and talk to an elder law attorney about power of attorney while it can still be signed.
What is worth asking a doctor about instead
A few things genuinely do affect cognition, and they are testable rather than purchasable.
Dismissing every supplement claim as nonsense goes slightly too far, and families deserve the accurate version.
Deficiencies in vitamin B12, vitamin D, thyroid hormone and a handful of others can affect thinking, and correcting a genuine deficiency can genuinely help. That is why a proper dementia workup includes bloodwork. The difference is that this is tested for and treated, not bought from a video.
It is also worth reviewing the medication list for drugs that worsen cognition — a real, evidence-based intervention that costs nothing. See our guides to anticholinergic burden and the medications people don't realize are on that list.
And if someone in your family wants to do something — because that urge is real and deserves an outlet — the things with actual evidence behind them are unglamorous and free: treating hearing loss, controlling blood pressure, physical activity, sleep, and staying socially connected.
Frequently asked questions
Are any supplements proven to treat Alzheimer's?
The advert showed a famous person recommending it. Is that real?
How do I stop the purchases without taking away their independence?
How do I report one of these products?
The real answers are less exciting and they work.
Day to Day Dementia exists because families deserve better information than whatever the algorithm serves them at midnight. Join the waitlist for guides written by people who have been where you are.
Become a founding memberSources
- U.S. Food and Drug Administration. Unproven Alzheimer's Disease Products.
- U.S. Food and Drug Administration. Health Fraud Scams — how to report a problem.
- Federal Trade Commission. ReportFraud.ftc.gov.
- MyAntiSpyware. Analysis of the "MemoHoney" cinnamon-and-honey ritual promotion and its fabricated endorsement, July 2026.